Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
Clinical trial NCT03051607 · TERMINATED
Trial details
- NCT number
- NCT03051607
- Sponsor
- Biotie Therapies Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2018-01-16
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.